• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚西部高地耐药疟疾的分子流行病学

Molecular epidemiology of drug-resistant malaria in western Kenya highlands.

作者信息

Zhong Daibin, Afrane Yaw, Githeko Andrew, Cui Liwang, Menge David M, Yan Guiyun

机构信息

Program in Public Health, College of Health Sciences, University of California at Irvine, Irvine, CA 92697, USA.

出版信息

BMC Infect Dis. 2008 Jul 31;8:105. doi: 10.1186/1471-2334-8-105.

DOI:10.1186/1471-2334-8-105
PMID:18671871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2533336/
Abstract

BACKGROUND

Since the late 1980s a series of malaria epidemics has occurred in western Kenya highlands. Among the possible factors that may contribute to the highland malaria epidemics, parasite resistance to antimalarials has not been well investigated.

METHODS

Using parasites from highland and lowland areas of western Kenya, we examined key mutations associated with Plasmodium falciparum resistance to sulfadoxine - pyrimethamine and chloroquine, including dihydrofolate reductase (pfdhfr) and dihydropteroate synthetase (pfdhps), chloroquine resistance transporter gene (pfcrt), and multi-drug resistance gene 1 (pfmdr1).

RESULTS

We found that >70% of samples harbored 76T pfcrt mutations and over 80% of samples harbored quintuple mutations (51I/59R/108N pfdhfr and 437G/540E pfdhps) in both highland and lowland samples. Further, we did not detect significant difference in the frequencies of these mutations between symptomatic and asymptomatic malaria volunteers, and between highland and lowland samples.

CONCLUSION

These findings suggest that drug resistance of malaria parasites in the highlands could be contributed by the mutations and their high frequencies as found in the lowland. The results are discussed in terms of the role of drug resistance as a driving force for malaria outbreaks in the highlands.

摘要

背景

自20世纪80年代末以来,肯尼亚西部高地发生了一系列疟疾疫情。在可能导致高地疟疾疫情的因素中,寄生虫对抗疟药物的耐药性尚未得到充分研究。

方法

我们使用来自肯尼亚西部高地和低地的寄生虫,检测了与恶性疟原虫对磺胺多辛-乙胺嘧啶和氯喹耐药性相关的关键突变,包括二氢叶酸还原酶(pfdhfr)、二氢蝶酸合酶(pfdhps)、氯喹耐药转运蛋白基因(pfcrt)和多药耐药基因1(pfmdr1)。

结果

我们发现,在高地和低地样本中,超过70%的样本携带76T pfcrt突变,超过80%的样本携带五重突变(51I/59R/108N pfdhfr和437G/540E pfdhps)。此外,我们未检测到有症状和无症状疟疾志愿者之间以及高地和低地样本之间这些突变频率的显著差异。

结论

这些发现表明,高地疟原虫的耐药性可能是由低地发现的突变及其高频率所致。从耐药性作为高地疟疾暴发驱动力的作用方面对结果进行了讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db3/2533336/37846a689270/1471-2334-8-105-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db3/2533336/37846a689270/1471-2334-8-105-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db3/2533336/37846a689270/1471-2334-8-105-1.jpg

相似文献

1
Molecular epidemiology of drug-resistant malaria in western Kenya highlands.肯尼亚西部高地耐药疟疾的分子流行病学
BMC Infect Dis. 2008 Jul 31;8:105. doi: 10.1186/1471-2334-8-105.
2
Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.巴基斯坦南部地区疟原虫现场分离株中与耐药性相关的多态性的流行情况。
Malar J. 2011 Jan 28;10:18. doi: 10.1186/1475-2875-10-18.
3
Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).赤道几内亚巴塔地区恶性疟原虫pfdhfr、pfdhps、pfmdr1和pfcrt基因的分子突变概况与对不同抗疟药物的耐药性相关
Malar J. 2017 Jan 13;16(1):28. doi: 10.1186/s12936-016-1672-0.
4
Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.肯尼亚西部低地和高地地区恶性疟原虫种群的遗传结构及抗疟药物耐药性
Infect Genet Evol. 2009 Sep;9(5):806-12. doi: 10.1016/j.meegid.2009.04.015. Epub 2009 May 4.
5
Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: Prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes.喀麦隆中部和阿达马瓦地区的抗疟药耐药性:疟原虫 CRT、Pfmdr1、Pfdhfr 和 Pfdhps 基因的突变流行率。
PLoS One. 2021 Aug 19;16(8):e0256343. doi: 10.1371/journal.pone.0256343. eCollection 2021.
6
Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.在伊朗将磺胺多辛-乙胺嘧啶作为一线治疗药物引入之前,恶性疟原虫分离株中与抗疟药物相关的突变流行情况。
Malar J. 2007 Nov 13;6:148. doi: 10.1186/1475-2875-6-148.
7
Molecular Evidence for Resistance to Sulfadoxine-Pyrimethamine but Absence of Mutations in Mangaluru, Southwestern India.分子证据表明印度西南部芒格洛尔地区对磺胺多辛-乙胺嘧啶具有耐药性,但不存在突变。
Am J Trop Med Hyg. 2018 Dec;99(6):1508-1510. doi: 10.4269/ajtmh.18-0549.
8
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.乌干达高疟疾传播地区介导抗疟药物耐药性分子标志物流行率的时间变化。
Am J Trop Med Hyg. 2014 Jul;91(1):54-61. doi: 10.4269/ajtmh.13-0647. Epub 2014 May 5.
9
Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.尼日尔中南部季节性疟疾化学预防地区对氨苯砜-磺胺多辛加阿莫地喹耐药的分子标志物。
Malar J. 2018 Feb 27;17(1):98. doi: 10.1186/s12936-018-2242-4.
10
Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.印度奥里萨邦两种不同生态类型中恶性疟原虫耐药基因的突变流行情况比较评估。
Infect Genet Evol. 2016 Jul;41:47-55. doi: 10.1016/j.meegid.2016.03.014. Epub 2016 Mar 15.

引用本文的文献

1
High connectivity and low differentiation of Plasmodium falciparum parasite populations in a setting with high seasonal migration.在季节性迁移频繁的环境中,恶性疟原虫种群具有高连通性和低分化性。
Res Sq. 2025 Jul 2:rs.3.rs-6771360. doi: 10.21203/rs.3.rs-6771360/v1.
2
Persistence of markers of chloroquine resistance among isolates recovered from two Nigerian communities.从尼日利亚两个社区分离出的菌株中氯喹抗性标志物的持续性。
Malariaworld J. 2014 Feb 26;5:3. doi: 10.5281/zenodo.10878545. eCollection 2014.
3
Influence of blood group, Glucose-6-phosphate dehydrogenase and Haemoglobin genotype on Falciparum malaria in children in Vihiga highland of Western Kenya.

本文引用的文献

1
Malaria Epidemics at Exceptionally High Altitudes.极高海拔地区的疟疾流行
Br Med J. 1945 Jul 14;2(4410):45-7. doi: 10.1136/bmj.2.4410.45.
2
Plasmodium falciparum genetic diversity in western Kenya highlands.肯尼亚西部高地的恶性疟原虫基因多样性
Am J Trop Med Hyg. 2007 Dec;77(6):1043-50.
3
Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China.中国云南省恶性疟原虫氯喹耐药性的分子分析
在肯尼亚西部维希加高地,血型、葡萄糖-6-磷酸脱氢酶和血红蛋白基因型对恶性疟原虫疟疾在儿童中的影响。
BMC Infect Dis. 2020 Jul 9;20(1):487. doi: 10.1186/s12879-020-05216-y.
4
A seven-year surveillance of epidemiology of malaria reveals travel and gender are the key drivers of dispersion of drug resistant genotypes in Kenya.一项为期七年的疟疾流行病学监测显示,旅行和性别是肯尼亚耐药基因型传播的主要驱动因素。
PeerJ. 2020 Mar 12;8:e8082. doi: 10.7717/peerj.8082. eCollection 2020.
5
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.青蒿琥酯-阿莫地喹和青蒿琥酯-氨酚喹啉治疗后预防疟疾的持续时间以及 pfmdr1 86Y 和 pfcrt 76T 的影响:个体患者数据的荟萃分析。
BMC Med. 2020 Feb 25;18(1):47. doi: 10.1186/s12916-020-1494-3.
6
Multiplicity and molecular epidemiology of Plasmodium vivax and Plasmodium falciparum infections in East Africa.东非地区间日疟原虫和恶性疟原虫感染的多发性和分子流行病学。
Malar J. 2018 May 2;17(1):185. doi: 10.1186/s12936-018-2337-y.
7
Impacts of Antimalarial Drugs on Drug Resistance Markers, Western Kenya, 2003-2015.抗疟药物对 2003-2015 年肯尼亚西部耐药标志物的影响。
Am J Trop Med Hyg. 2018 Mar;98(3):692-699. doi: 10.4269/ajtmh.17-0763. Epub 2018 Jan 18.
8
Pooled-DNA sequencing identifies genomic regions of selection in Nigerian isolates of Plasmodium falciparum.混合DNA测序鉴定恶性疟原虫尼日利亚分离株中的选择基因组区域。
Parasit Vectors. 2017 Jun 29;10(1):320. doi: 10.1186/s13071-017-2260-z.
9
Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.阿奇霉素-氯喹与周效磺胺-乙胺嘧啶用于非洲孕妇恶性疟原虫疟疾感染间歇性预防治疗的疗效与安全性:一项开放标签随机试验
PLoS One. 2016 Jun 21;11(6):e0157045. doi: 10.1371/journal.pone.0157045. eCollection 2016.
10
Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.安哥拉卢班戈恶性疟原虫对低剂量磺胺多辛-乙胺嘧啶的耐药性
Malar J. 2016 Jun 7;15:309. doi: 10.1186/s12936-016-1358-7.
Trop Med Int Health. 2007 Sep;12(9):1051-60. doi: 10.1111/j.1365-3156.2007.01882.x.
4
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.pfmdr1在非洲恶性疟原虫对蒿甲醚-本芴醇耐受性中的作用。
Trop Med Int Health. 2007 Jun;12(6):736-42. doi: 10.1111/j.1365-3156.2007.01843.x.
5
Reconciling national treatment policies and drug regulation in Kenya.协调肯尼亚的国民待遇政策与药品监管
Health Policy Plan. 2007 Mar;22(2):111-2. doi: 10.1093/heapol/czl038. Epub 2007 Jan 15.
6
Monitoring chloroquine resistance using Plasmodium falciparum parasites isolated from wild mosquitoes in Tanzania.利用从坦桑尼亚野生蚊子中分离出的恶性疟原虫监测氯喹耐药性。
Am J Trop Med Hyg. 2006 Dec;75(6):1182-7.
7
Return of chloroquine antimalarial efficacy in Malawi.氯喹在马拉维抗疟疗效的恢复
N Engl J Med. 2006 Nov 9;355(19):1959-66. doi: 10.1056/NEJMoa062032.
8
Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles.恶性疟原虫中的抗叶酸耐药性:多种起源及新型二氢叶酸还原酶等位基因的鉴定
J Infect Dis. 2006 Jul 15;194(2):189-97. doi: 10.1086/504687. Epub 2006 Jun 13.
9
Population dynamics of malaria vectors in western Kenya highlands.肯尼亚西部高地疟疾媒介的种群动态
J Med Entomol. 2006 Mar;43(2):200-6. doi: 10.1603/0022-2585(2006)043[0200:pdomvi]2.0.co;2.
10
Malaria in Kenya's western highlands.肯尼亚西部高地的疟疾
Emerg Infect Dis. 2005 Sep;11(9):1425-32. doi: 10.3201/eid1109.041131.